189 related articles for article (PubMed ID: 9365167)
1. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix.
West CM; Davidson SE; Roberts SA; Hunter RD
Br J Cancer; 1997; 76(9):1184-90. PubMed ID: 9365167
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma.
Levine EL; Renehan A; Gossiel R; Davidson SE; Roberts SA; Chadwick C; Wilks DP; Potten CS; Hendry JH; Hunter RD
Radiother Oncol; 1995 Oct; 37(1):1-9. PubMed ID: 8539450
[TBL] [Abstract][Full Text] [Related]
3. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
Stausbøl-Grøn B; Overgaard J
Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix.
West CM; Davidson SE; Roberts SA; Hunter RD
Br J Cancer; 1993 Oct; 68(4):819-23. PubMed ID: 8398714
[TBL] [Abstract][Full Text] [Related]
5. Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity.
Cooper RA; West CM; Wilks DP; Logue JP; Davidson SE; Roberts SA; Hunter RD
Br J Cancer; 1999 Sep; 81(2):354-8. PubMed ID: 10496365
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
[TBL] [Abstract][Full Text] [Related]
7. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
Yeh SA; Wan Leung S; Wang CJ; Chen HC
Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy.
Nishioka T; West CM; Gupta N; Wilks DP; Hendry JH; Davidson SE; Hunter RD
J Cancer Res Clin Oncol; 1999; 125(2):96-100. PubMed ID: 10190316
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment plasma TGF beta 1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix.
Dickson J; Davidson SE; Hunter RD; West CM
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):991-5. PubMed ID: 11072155
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of anemia for patients with cervical cancer treated with irradiation].
Grigiene R; Aleknavicius E; Kurtinaitis J
Medicina (Kaunas); 2005; 41(11):916-24. PubMed ID: 16333214
[TBL] [Abstract][Full Text] [Related]
11. [Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?].
Recoules-Arche A; Rouzier R; Rey A; Villefranque V; Haie-Meder C; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D; Morice P
Gynecol Obstet Fertil; 2004 Feb; 32(2):116-21. PubMed ID: 15123133
[TBL] [Abstract][Full Text] [Related]
12. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
Tan LT; Jones B; Gee A; Kingston RE
Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
[TBL] [Abstract][Full Text] [Related]
13. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data.
West CM; Davidson SE; Burt PA; Hunter RD
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):841-6. PubMed ID: 7860397
[TBL] [Abstract][Full Text] [Related]
14. Galectin-1 is an independent prognostic factor for local recurrence and survival after definitive radiation therapy for patients with squamous cell carcinoma of the uterine cervix.
Huang EY; Chanchien CC; Lin H; Wang CC; Wang CJ; Huang CC
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):975-82. PubMed ID: 24139517
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
[TBL] [Abstract][Full Text] [Related]
16. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
Gasińska A; Urbański K; Jakubowicz J; Klimek M; Biesaga B; Wilson GD
Radiother Oncol; 1999 Jan; 50(1):77-84. PubMed ID: 10225560
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer.
Wimberger P; Hillemanns P; Kapsner T; Hepp H; Kimmig R
Anal Cell Pathol; 2002; 24(4-5):147-58. PubMed ID: 12590151
[TBL] [Abstract][Full Text] [Related]
18. Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers.
Björk-Eriksson T; West C; Karlsson E; Mercke C
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):13-9. PubMed ID: 10656366
[TBL] [Abstract][Full Text] [Related]
19. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity.
Davidson SE; West CM; Roberts SA; Hendry JH; Hunter RD
Radiother Oncol; 1990 Aug; 18(4):349-56. PubMed ID: 2244021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
